88 results
424B3
RGBP
Regen BioPharma Inc
24 Apr 24
Prospectus supplement
1:28pm
Fees are recognized upon satisfaction of all conditions required to be satisfied in order for that revenue to have been earned by the Company.
M … , 2018 the Company accepted 725,000 shares of the Series M Preferred stock of Zander Therapeutics, Inc. in satisfaction of prepaid rent and accrued
424B3
RGBP
Regen BioPharma Inc
19 Jan 24
Prospectus supplement
1:29pm
satisfaction of all conditions required to be satisfied in order for that revenue to have been earned by the Company.
M. INTEREST RECEIVABLE … accepted 725,000 shares of the Series M Preferred stock of Zander Therapeutics, Inc. in satisfaction of prepaid rent and accrued interest owed
424B3
RGBP
Regen BioPharma Inc
20 Nov 23
Prospectus supplement
9:38am
shares in satisfaction of $761,500 of convertible indebtedness and $380,262 of accrued interest on convertible indebtedness.
On November 11, 2022 … the Company issued 11,279 common shares in satisfaction of $25,639 of accrued interest on convertible indebtedness.
On December 5, 2022 the Company issued
424B3
93id5 f0ofq1kbw
2 Oct 23
Prospectus supplement
1:42pm
8-K
EX-10.1
ge26rkjgwkg
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.2
rzl2s97
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.3
vr4oezdyzbe51
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
424B3
tufr0s31oooc3fu6c
15 May 23
Prospectus supplement
10:25am